Hormone Replacement Therapy Market: Global Industry Analysis, Trends, Market Size & Forecasts to 2023

  • ID: 4427148
  • Report
  • Region: Global
  • 120 pages
  • Infinium Global Research
1 of 4

FEATURED COMPANIES

  • Amgen
  • Bayer
  • Eli Lily
  • Genentech
  • MED-EL
  • Merck & Co.
  • MORE
The report on global hormone replacement therapy market provides qualitative and quantitative analysis for the period of 2015 to 2023. The report predicts the global hormone replacement therapy market to grow with a CAGR between 2.0% and 2.5% from 2017 to 2023. The global Hormone replacement therapy market was worth USD 5.97 billion in 2015. The study on hormone replacement therapy market covers the analysis of regions such as Americas, Europe, Asia Pacific, and Rest of the World. Among the geographies Americas dominated the world market while Asia-Pacific region is anticipated to grow at the highest CAGR over the forecast period.

The report on global Hormone replacement therapy market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the global Hormone replacement therapy market. Moreover, the report is collective presentation of primary and secondary research findings. In addition, it provides deep insights on the factors that are driving, restraining the global hormone replacement therapy market. Porter’s five forces model in the report provides insights into the competitive rivalry in the global Hormone replacement therapy market over the period of 2015 - 2023. Further. The growth matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
  • Primary Research
Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents.

The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through:
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers

Primary research respondents typically include:
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:
  • Company reports and publications
  • Government/institutional publications
  • Trade and associations’ journals
  • Databases such as WTO, OECD, and World Bank, among others.
  • Websites and publications by research agencies
Report Findings

1. Drivers
  • Increasing in incidence of regularly monitored formulations
  • Technological advancement in drug delivery systems
  • Growing awareness among the patients
  • Reformulation of permitted drugs Restraints
2. Opportunities
  • Growing prevalence of the geriatric population
Segments Covered

1. Global Hormone replacement therapy market by Type
a. Growth hormone replacement therapy
b. Estrogen replacement therapy
c. Thyroid Hormone Replacement Therapy Receiver-in-ear

2. Global Hormone replacement therapy market by Route of administration
a. Oral
b. Parenteral
c. transdermal

Companies Profiled:

The companies covered in the report include:
  • Amgen
  • Genentech
  • Novo Nordisk
  • Wyeth
  • Bayer
  • MED-EL
  • Eli Lily
  • Merck & Co.
  • Mylan Laboratories
  • Pfizer
Reasons to buy this report
1. Comprehensive analysis of global as well as regional markets of Hormone replacement therapy
2. Complete coverage of all the product type and Route of Administration segments to analyze the trends, developments in Hormone replacement therapy market, and forecast of market size up to 2023.
3. Comprehensive analysis of the companies operating in Hormone replacement therapy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen
  • Bayer
  • Eli Lily
  • Genentech
  • MED-EL
  • Merck & Co.
  • MORE
1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches

2. Executive Summary

3. Global Hormone replacement therapy Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.2.4 Challenges
3.3 Porter’s Five Forces Analysis
3.4 Growth Matrix Analysis
3.5 Competitive Landscape in the Hormone replacement therapy Market

4. Global Hormone Replacement Therapy Market: Snapshot
4.1 Global Hormone replacement therapy market key trends
4.2 Global Hormone replacement therapy market by Type
4.3 Global Hormone replacement therapy market by route of administration

5. Global Hormone Replacement Therapy Market By Type (USD Million) 2017-2023
5.1 Growth hormone replacement therapy
5.2 Estrogen replacement therapy
5.3 Thyroid Hormone Replacement Therapy.

6. Global Hormone Replacement Therapy Market By Route of Administration (USD Million) 2017-2023
6.1 Oral
6.2 Parenteral
6.3 Transdermal

7. Global Hormone Replacement Therapy Market Analysis, by Region (USD Million) 2017-2023
7.1 Americas
7.1.1 Americas Hormone replacement therapy Market by Type (USD Million)
7.1.2 Americas Hormone replacement therapy Market by Route of Administration (USD Million)
7.1.3 Americas Hormone replacement therapy Market by country (USD Million)
7.2 Europe
7.2.1 Europe Hormone replacement therapy Market by Type (USD Million)
7.2.2 Europe Hormone replacement therapy Market by Route of Administration (USD Million)
7.2.3 Europe Hormone replacement therapy Market by country (USD Million)
7.3 Asia-Pacific
7.3.1 Asia-Pacific Hormone replacement therapy Market by Type (USD Million)
7.3.2 Asia-Pacific Hormone replacement therapy Market by Route of Administration (USD Million)
7.3.3 Asia-Pacific Hormone replacement therapy Market by country (USD Million)
7.4 Rest of the World (RoW)
7.4.1 RoW Hormone replacement therapy Market by Type (USD Million)
7.4.2 RoW Hormone replacement therapy Market by Route of Administration (USD Million)
7.4.3 RoW Hormone replacement therapy Market by country (USD Million)

8. Company Profiles
8.1 Amgen.
8.2 Genentech
8.3 Novo Nordisk, Wyeth
8.4 Bayer
8.5 MED-EL
8.6 Eli Lily, LLC
8.7 Merck & Co.
8.8 Mylan Laboratories
8.9 Pfizer
8.10 Novartis
8.11 Abbott Laboratories
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Amgen
  • Genentech
  • Novo Nordisk
  • Wyeth
  • Bayer
  • MED-EL
  • Eli Lily
  • Merck & Co.
  • Mylan Laboratories
  • Pfizer
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll